Literature DB >> 33892713

Trunk fat volume can be a predictor of postoperative complications after gastrectomy: a retrospective cohort study.

Shinichiro Shiomi1, Tetsuro Toriumi1, Koichi Yagi1, Raito Asaoka1, Yasuhiro Okumura1, Kotaro Wakamatsu1, Susumu Aikou1, Hiroharu Yamashita1, Sachiyo Nomura1, Yasuyuki Seto2.   

Abstract

BACKGROUND: Obesity can affect postoperative outcomes of gastrectomy. Visceral fat area is superior to body mass index in predicting postoperative complications. However, visceral fat area measurement is time-consuming and is not optimum for clinical use. Meanwhile, trunk fat volume (TFV) can be easily measured via bioelectrical impedance analysis. Hence, the current study aimed to determine the ability of TFV to predict the occurrence of complications after gastrectomy.
METHODS: We retrospectively reviewed patients who underwent curative gastrectomy for gastric cancer between November 2016 and November 2019. The trunk fat volume-to-the ideal amount (%TFV) ratio was obtained using InBody 770 before surgery. The patients were classified into the obese and nonobese groups according to %TFV (TFV-H group, ≥ 150%; TFV-L group, < 150%) and body mass index (BMI-H group, ≥ 25 kg/m2; BMI-L group, < 25 kg/m2). We compared the short-term postoperative outcomes (e.g., operative time, blood loss volume, number of resected lymph nodes, and duration of hospital stay) between the obese and nonobese patients. Risk factors for complications were assessed using logistic regression analysis.
RESULTS: In total, 232 patients were included in this study. The TFV-H and BMI-H groups had a significantly longer operative time than the TFV-L (p = 0.022) and BMI-L groups (p = 0.006). Moreover, the TFV-H group had a significantly higher complication rate (p = 0.004) and a lower number of resected lymph nodes (p < 0.001) than the TFV-L group. In the univariate analysis, %TFV ≥ 150, total or proximal gastrectomy, and open gastrectomy were found to be potentially associated with higher complication rates (p < 0.1 for all). Moreover, the multivariate analysis revealed that %TFV ≥ 150 (OR: 2.73; 95% CI: 1.37-5.46; p = 0.005) and total or proximal gastrectomy (OR: 3.57; 95% CI: 1.79-7.12; p < 0.001) were independently correlated with postoperative morbidity.
CONCLUSIONS: %TFV independently affected postoperative complications. Hence, it may be a useful parameter for the evaluation of obesity and a predictor of complications after gastrectomy.

Entities:  

Keywords:  Gastrectomy; Intra-abdominal fat; Obesity; Postoperative complication

Year:  2021        PMID: 33892713     DOI: 10.1186/s12893-021-01221-3

Source DB:  PubMed          Journal:  BMC Surg        ISSN: 1471-2482            Impact factor:   2.102


  2 in total

1.  The Incidence of Postoperative Complications after Gastrectomy Increases in Proportion to the Amount of Preoperative Visceral Fat.

Authors:  Kazuyuki Okada; Tatsuto Nishigori; Kazutaka Obama; Shigeru Tsunoda; Koya Hida; Shigeo Hisamori; Yoshiharu Sakai
Journal:  J Oncol       Date:  2019-12-16       Impact factor: 4.375

2.  Prediction of the Risk of Laparoscopy-Assisted Gastrectomy by Comparing Visceral Fat Area and Body Mass Index.

Authors:  Yongke Liu; Dong Guo; Zhaojian Niu; Yuliang Wang; Guanghua Fu; Yanbing Zhou; Qingkai Xue; Xinliang Jin; Zhiqi Gong
Journal:  Gastroenterol Res Pract       Date:  2018-09-13       Impact factor: 2.260

  2 in total
  2 in total

1.  Muscle mass ratio in male gastric cancer patients as an independent predictor of postoperative complications after minimally invasive distal gastrectomy.

Authors:  Gaku Inaguma; Susumu Shibasaki; Masaya Nakauchi; Akiko Serizawa; Kenichi Nakamura; Shingo Akimoto; Tanaka Tsuyoshi; Kazuki Inaba; Ichiro Uyama; Koichi Suda
Journal:  Surg Endosc       Date:  2022-09-09       Impact factor: 3.453

2.  Effect of Combining Early Chemotherapy with Zhipu Liujunzi Decoction under the Concept of Strengthening and Consolidating Body Resistance for Gastric Cancer Patients and Nursing Strategy.

Authors:  Min Wang; Shujuan Wang; Qiang Su; Tian Ma
Journal:  Contrast Media Mol Imaging       Date:  2021-11-30       Impact factor: 3.161

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.